12 Facts About Sandoz Pharmaceuticals

In March 1996, the companies Ciba-Geigy and Sandoz Pharmaceuticals merged to form Novartis; the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity.

The Sandoz Pharmaceuticals brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz Pharmaceuticals.

Sandoz Pharmaceuticals began producing the fever-reducing drug antipyrin in the same year.

Sandoz Pharmaceuticals produced chemicals for textiles, paper, and leather, beginning in 1929.

Sandoz Pharmaceuticals suggested in its marketing literature that psychiatrists take LSD themselves, to gain a better subjective understanding of the schizophrenic experience, and many did exactly that and so did other scientific researchers.

Related searches

The Sandoz Pharmaceuticals product received mass publicity as early as 1954, in a Time Magazine feature.

Sandoz Pharmaceuticals acquired the companies Delmark, Wasabrod, and Gerber Products Company (a baby food company).

In 1995, Sandoz Pharmaceuticals spun off its specialty chemicals business to form Clariant.

Also in 2006, Sandoz Pharmaceuticals became the first company to have a biosimilar drug approved in Europe with its recombinant human growth hormone drug.

In November 2019, Sandoz Pharmaceuticals announced it would acquire the Japanese business of Aspen Global inc for €300 million, boosting the business's presence in Asia.

Sandoz Pharmaceuticals is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.

In September 2008, the US Food and Drug Administration sent a notice to Novartis Sandoz Pharmaceuticals regarding its advertising of Focalin XR, an ADHD drug, in which the company overstated its efficacy while marketing to the public and medical professionals.